ESAB Corp Liquidation Value

Cash & Equivalents

$1.00B
As of 2026-04-03
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $1.00B
Total Obligations: -$2.95B
$-1.94B
Per share: $-31.91
Period: 2026-04-03

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $1.00B
AR: $488.46M
Total Obligations: -$2.95B
$-1.45B
Per share: $-23.89
Period: 2026-04-03

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $1.00B
AR: $488.46M
Inventory: $520.60M
Total Obligations: -$2.95B
$-933.98M
Per share: $-15.34
Period: 2026-04-03

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-1.94B$-31.91
Liquid Liquidation Value$-1.45B$-23.89
Operating Liquidation Value$-933.98M$-15.34

Key Components (as of 2026-04-03)

Data as of 2026-04-03 from 10-Q filed 2026-05-07. View on SEC EDGAR →

Cash & Equivalents$1.00B
Accounts Receivable$488.46M
Inventory$520.60M
Current Liabilities$730.00M
Long-term Debt (?)$2.03B
Op. Lease Liability (?)$81.54M
Finance Lease (?)N/A
Shares Outstanding60.9M

Explore all 160 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-04-03$1.00B$488.46M$520.60M$398.50M$730.00M$2.03B$81.54MN/A
2025-12-31$185.86M$451.30M$481.76M$360.39M$664.79M$1.23B$88.14MN/A
2025-10-03$218.22M$460.47M$503.72M$342.21M$669.07M$1.33B$108.17MN/A
2025-07-04$258.22M$456.11M$474.10M$369.52M$686.47M$1.06B$65.35MN/A
2025-04-04$291.35M$414.80M$450.70M$349.72M$672.00M$1.06B$62.55MN/A
2024-12-31$249.36M$370.32M$403.71M$318.49M$632.05M$1.06B$66.04MN/A
2024-09-27$253.67M$420.94M$422.65M$320.25M$637.07M$1.08B$70.06MN/A
2024-06-28$228.47M$431.21M$426.52M$350.12M$651.10M$1.08B$70.19MN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-04-03 10-Q 2026-05-07 View
2025-12-31 10-K 2026-02-20 View
2025-10-03 10-Q 2025-10-29 View
2025-07-04 10-Q 2025-08-06 View
2025-04-04 10-Q 2025-05-01 View
2024-12-31 10-K 2025-02-20 View
2024-09-27 10-Q 2024-10-29 View
2024-06-28 10-Q 2024-08-02 View

AI Insights

AI Insight·Generated 2026-05-09

ESAB Corp (ESAB) presents a deeply negative liquidation posture as of April 3, 2026, consistent with the MFFAIS CLV of approximately -$1.84B and OLV of approximately -$830M. The balance sheet is dominated by intangible assets that carry zero liquidation value: goodwill of $1.93B and other intangibles of $656M together represent approximately $2.59B of book assets that vaporize under the liquidation lens. Total reported assets of $5.62B, after applying standard haircuts (cash at 100%, AR at 90-95%, inventory at 60%, PP&E at 50-70%, intangibles/goodwill at 0%), yield estimated recoverable value in the range of $2.3-2.5B against total liabilities of $3.39B carried at face value, producing a recovery deficit well in excess of $1B. Key liability concentrations compounding the shortfall include: long-term debt of $2.03B (face principal $2.06B per DebtInstrumentCarryingAmount), operating lease liabilities totaling $104M (current $22M, noncurrent $82M), pension and asbestos-related contingent liabilities embedded in OtherLiabilitiesNoncurrent of $627M which includes the disclosed asbestos reserve of $307M (current $44M + noncurrent $263M), and deferred tax liabilities of $176M. Asbestos insurance receivables of $248M ($232M current + $16M noncurrent) net against the gross asbestos obligation but remain subject to insurer solvency risk and are not cash in hand. The most significant change from the prior period (December 31, 2025 10-K) is the issuance of $1.0B in 2031 Senior Notes in Q1 2026, which increased reported cash to $1.0B (up $819M from $186M at year-end) but simultaneously added $1.0B to the debt stack. Net debt position therefore changed minimally; the cash is pre-positioned for the pending Eddyfi Technologies acquisition ($1.45B purchase price). Post-close, assuming the Eddyfi deal funds entirely through the Senior Notes plus committed equity financing of ~$318M (Mandatory Convertible Preferred + common stock), the liability stack will expand materially before any acquired tangibles are realizable. Americas segment assets grew $414M QoQ to $2.13B, primarily acquisition-driven. EMEA & APAC assets grew $445M to $3.49B. PP&E of $377M is geographically dispersed across 20+ countries, reducing orderly liquidation recovery probability and introducing cross-border execution risk. Restructuring charges of $10.2M in Q1 2026 (vs. $4.5M in Q1 2025) reflect active facility closures, which modestly reduce PP&E carrying value through impairment charges captured in the restructuring line. Filing discusses asbestos liability projections and insurance recovery in MD&A narrative but does not separately tag the gross asbestos obligation or the insurance recovery asset in distinct XBRL concepts beyond LossContingencyAccrualCarryingValueCurrent and LossContingencyReceivableCurrent.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...